Determination Letter Alleges IRB Approved Research Without Sufficient Information

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Determination Letter Alleges IRB Approved Research Without Sufficient Information

J.W. Schomisch

July 7, 2024 at 02:39 PM EST

Emory University received a June 17 Determination Letter from HHS’ Office for Human Research Protections (OHRP) concerning allegations that the university institutional review board (IRB) approved research without sufficient information. The university acknowledged “their IRB has documented conditions of IRB approval in a way that could be perceived as asking investigators op... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Determination Letter Alleges IRB Approved Research Without Sufficient Information

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT